Atlas Trials

Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

Clinical trial NCT03789006 · UNKNOWN

Trial details

NCT number
NCT03789006
Sponsor
University of Khartoum
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney Transplant Rejection
Start date
2018-03-21
Primary completion
2022-03-21
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.